Published in J Empir Res Hum Res Ethics on July 01, 2012
"Snake-oil," "quack medicine," and "industrially cultured organisms:" biovalue and the commercialization of human microbiome research. BMC Med Ethics (2012) 0.88
The policies of ethics committees in the management of biobanks used for research: an Italian survey. Eur J Hum Genet (2013) 0.78
Investigators' perspectives on translating human microbiome research into clinical practice. Public Health Genomics (2013) 0.75
Addressing Benefits, Risks and Consent in Next Generation Sequencing Studies. J Clin Res Bioeth (2015) 0.75
Navigating social and ethical challenges of biobanking for human microbiome research. BMC Med Ethics (2017) 0.75
Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research. Microbiome (2017) 0.75
The NIH Human Microbiome Project. Genome Res (2009) 24.61
Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38
Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics (2008) 12.10
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Genetics. Genomic research and human subject privacy. Science (2004) 6.56
Genetics. No longer de-identified. Science (2006) 6.20
Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet (2001) 6.07
Forensic identification using skin bacterial communities. Proc Natl Acad Sci U S A (2010) 4.56
Informed consent for population-based research involving genetics. JAMA (2001) 4.10
From patients to partners: participant-centric initiatives in biomedical research. Nat Rev Genet (2012) 3.44
Assessing the understanding of biobank participants. Am J Med Genet A (2009) 3.04
Consent documents for oncology trials: does anybody read these things? Am J Clin Oncol (2004) 2.49
The evolution of consent forms for research: a quarter century of changes. IRB (2010) 1.92
The Human Microbiome Project in 2011 and beyond. Cell Host Microbe (2011) 1.89
Informed consent: how much does the patient understand? Clin Pharmacol Ther (1980) 1.50
Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res (2008) 1.10
"Who owns your poop?": insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics (2011) 0.94
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med (2007) 3.55
Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol (2005) 3.44
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Metagenomic pyrosequencing and microbial identification. Clin Chem (2009) 2.81
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med (2008) 2.24
Human microbiome in health and disease. Annu Rev Pathol (2011) 2.18
Equipoise lost: ethics, costs, and the regulation of cancer clinical research. J Clin Oncol (2010) 2.16
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13
A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 1.98
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis (2006) 1.78
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 1.77
The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol (2009) 1.62
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis (2003) 1.57
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol (2009) 1.55
To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med (2011) 1.52
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol (2003) 1.50
Barriers and incentives to orphan care in a time of AIDS and economic crisis: a cross-sectional survey of caregivers in rural Zimbabwe. BMC Public Health (2006) 1.43
Alcohol recovery and spirituality: strangers, friends, or partners? South Med J (2006) 1.39
Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes (2011) 1.38
Responses to open peer commentaries on "Physicians' silent decisions: because patient autonomy doesn't always come first". Am J Bioeth (2007) 1.38
Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine (2005) 1.37
Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun (2005) 1.37
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol (2013) 1.35
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users. AIDS Behav (2007) 1.33
HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev (2009) 1.33
HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health (2009) 1.32
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe (2008) 1.30
Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol (2008) 1.30
Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics (2011) 1.30
DNA pyrosequencing-based bacterial pathogen identification in a pediatric hospital setting. J Clin Microbiol (2007) 1.30
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 1.28
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis (2011) 1.28
Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One (2011) 1.25
Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis (2002) 1.23
Decisions to participate in research: views of underserved minority drug users with or at risk for HIV. AIDS Care (2008) 1.23
Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol (2008) 1.23
DNA pyrosequencing-based identification of pathogenic Candida species by using the internal transcribed spacer 2 region. Arch Pathol Lab Med (2008) 1.23
Missed expectations? Physicians' views of patients' participation in medical decision-making. Med Care (2005) 1.22
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine (2007) 1.20
Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. Am J Trop Med Hyg (2008) 1.19
The python's embrace: clinical research regulation by institutional review boards. Pediatrics (2012) 1.19
Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16
The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Appl Environ Microbiol (2007) 1.15
Multiple Epstein-Barr virus infections in healthy individuals. J Virol (2003) 1.15
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob Agents Chemother (2008) 1.11
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res (2008) 1.10
Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis (2013) 1.09
Pandemic H5N1 influenza vaccine development: an update. Expert Rev Vaccines (2008) 1.09
Rapid licensure of a new, inactivated influenza vaccine in the United States. Hum Vaccin (2005) 1.07
The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem (2013) 1.07
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine (2009) 1.07
Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J (2011) 1.05
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis (2003) 1.04
Participants' recall and understanding of genomic research and large-scale data sharing. J Empir Res Hum Res Ethics (2013) 1.03
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun (2002) 1.02
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol (2010) 1.02
Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol (2011) 1.01
Antibody quantity versus quality after influenza vaccination. Vaccine (2009) 1.01
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg (2005) 1.00
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine (2012) 0.99
Adjuvants for pandemic influenza vaccines. Curr Top Microbiol Immunol (2009) 0.99
High prevalence of stigma-related abuse among a sample of men who have sex with men in Tanzania: implications for HIV prevention. AIDS Care (2014) 0.99
How can probiotics and prebiotics impact mucosal immunity? Gut Microbes (2010) 0.98
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. J Infect Dis (2012) 0.98
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine (2009) 0.98
The lives of female sex workers in Vietnam: Findings from a qualitative study. Cult Health Sex (2007) 0.97
A theme issue by, for, and about Africa: new injecting practice increases HIV risk among drug users in Tanzania. BMJ (2005) 0.96
Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis (2009) 0.96
Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines (2008) 0.96
Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines (2010) 0.96
Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol (2014) 0.94
Significant morbidity and mortality attributable to rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr Hematol Oncol (2013) 0.94
Lactobacillus saerimneri and Lactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities. FEMS Microbiol Lett (2009) 0.93
Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr (2012) 0.93
Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol (2009) 0.93
Promoting knowledge of statins in patients with low health literacy using an audio booklet. Patient Prefer Adherence (2011) 0.92
Psychosocial disadvantage: preparation, grieving, remembrance and recovery for orphans in eastern Zimbabwe. Afr J AIDS Res (2006) 0.91
HIV update. Diagnostic tests and markers of disease progression and response to therapy. Am J Clin Pathol (2002) 0.90
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS (2003) 0.88
"Snake-oil," "quack medicine," and "industrially cultured organisms:" biovalue and the commercialization of human microbiome research. BMC Med Ethics (2012) 0.88
Prevalence of HIV risk behaviors among undocumented Central American immigrant women in Houston, Texas. AIDS Behav (2012) 0.87
Psychological correlates of trading sex for money among African American crack cocaine smokers. Am J Drug Alcohol Abuse (2006) 0.87
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. Vaccine (2011) 0.87
Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination. Influenza Other Respir Viruses (2007) 0.87
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87